Cargando…

The utility of pharmacogenetic testing to support the treatment of bipolar disorder

BACKGROUND: Bipolar disorder (BD) is a frequent cause of disability, health care costs, and risk of suicide. Pharmacogenetic tests (PGTs) could help clinicians to identify those patients predisposed to the occurrence of adverse events (AEs) improving the understanding of the correlation between gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ielmini, Marta, Poloni, Nicola, Caselli, Ivano, Espadaler, Jordi, Tuson, Miquel, Grecchi, Alessandro, Callegari, Camilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860421/ https://www.ncbi.nlm.nih.gov/pubmed/29588611 http://dx.doi.org/10.2147/PGPM.S160967

Ejemplares similares

Pharmacogenetic Tests in Reducing Accesses to Emergency Services and Days of Hospitalization in Bipolar Disorder: A 2-Year Mirror Analysis
por: Callegari, Camilla, et al.
Publicado: (2019)

Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
por: Panella, Lorenzo, et al.
Publicado: (2019)

Epidemiology and evolution of the diagnostic classification of factitious disorders in DSM-5
por: Caselli, Ivano, et al.
Publicado: (2017)

Medically Unexplained Physical Symptoms in Hospitalized Patients: A 9-Year Retrospective Observational Study
por: Poloni, Nicola, et al.
Publicado: (2018)

A naturalistic study on the relationship among resilient factors, psychiatric symptoms, and psychosocial functioning in a sample of residential patients with psychosis
por: Poloni, Nicola, et al.
Publicado: (2018)

Resilience and recovery style: a retrospective study on associations among personal resources, symptoms, neurocognition, quality of life and psychosocial functioning in psychotic patients
por: Zizolfi, Daniele, et al.
Publicado: (2019)

Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies
por: Vilches, Silvia, et al.
Publicado: (2019)

Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management
por: Poloni, Nicola, et al.
Publicado: (2019)

The North Italian innovative project for common psychiatric disorders: Evaluating the output of a treatment model of an outpatient clinic for anxiety and depression
por: Caselli, Ivano, et al.
Publicado: (2023)

Assessing Mental Pain as a Predictive Factor of Suicide Risk in a Clinical Sample of Patients with Psychiatric Disorders
por: Ielmini, Marta, et al.
Publicado: (2022)

Resilience, Cardiological Outcome, and Their Correlations With Anxious-Depressive Symptoms and Quality of Life in Patients With an Implantable Cardioverter Defibrillator
por: Isella, Celeste, et al.
Publicado: (2021)

The Impact of Covid-19 Pandemic on Mental Health Services: A Comparison Between First Psychiatric Consultations Before and After the Pandemic
por: Caselli, Ivano, et al.
Publicado: (2023)

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression
por: Anmella, Gerard, et al.
Publicado: (2021)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
por: Pérez, Víctor, et al.
Publicado: (2017)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

LITHIUM IN THE TREATMENT OF BIPOLAR DISORDER: PHARMACOLOGY AND PHARMACOGENETICS
por: Alda, Martin
Publicado: (2015)

The use of pharmacogenetic testing in patients with schizophrenia or bipolar disorder: A systematic review
por: Routhieaux, Melanie, et al.
Publicado: (2018)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
por: Blasco-Fontecilla, Hilario
Publicado: (2018)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

Reliability and validity of the Italian version of the 14-item Resilience Scale
por: Callegari, Camilla, et al.
Publicado: (2016)

Service Engagement: Psychopathology, Recovery Style and Treatments
por: Vender, Simone, et al.
Publicado: (2014)

Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic
por: Claudio‐Campos, Karla, et al.
Publicado: (2020)

Gluten encephalopathy with psychiatric onset: case report
por: Poloni, Nicola, et al.
Publicado: (2009)

Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy
por: Peña-Martín, María Celsa, et al.
Publicado: (2022)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Neural network analysis in pharmacogenetics of mood disorders
por: Serretti, Alessandro, et al.
Publicado: (2004)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
por: Falvella, Felicia Stefania, et al.
Publicado: (2015)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

Bipolar switching in chalcogenide phase change memory
por: Ciocchini, N., et al.
Publicado: (2016)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer
por: Bernard, Philip S., et al.
Publicado: (2021)

Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
por: Kusic, Dara, et al.
Publicado: (2022)

Positive perception of pharmacogenetic testing for psychotropic medications
por: Lanktree, Matthew B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_93hev1imflf3vdh05g1kpbcbb5